Latest Dilution News

ResMed Inc. reported a robust 9% increase in net revenue for Q1 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. Despite ongoing patent litigation, the company delivered a 12% rise in net income and boosted shareholder returns with a $150 million share repurchase.

ClearVue Technologies has secured a $4.6 million capital raise and signed major partnerships, setting the stage for commercialisation in 2026 with a robust $60 million project pipeline.

PARKD Limited has raised $1 million to fund its East Coast expansion, secured a new prefabrication facility in NSW, and landed its first pilot project with McNab Group, marking a pivotal step in its national rollout.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Atlantic Lithium has finalized revised fiscal terms with the Ghanaian government for its Ewoyaa Lithium Project and awaits parliamentary ratification, while reporting strong exploration results in Côte d’Ivoire and securing significant funding agreements.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Javelin Minerals Limited secured strong shareholder approval for all 16 resolutions at its 2025 Annual General Meeting, including capital consolidation and multiple share issuances.

Macarthur Minerals bolstered its financial position through a nearly A$2 million entitlement offer and strengthened governance with a key board appointment, setting the stage for advancing its Lake Giles Iron Ore Project.

Arcadia Minerals has secured a binding farm-in agreement with Kaoko Metals for its Karibib Copper Gold Project, unlocking immediate cash and future equity incentives while advancing exploration partnerships across its Namibian portfolio.

Bathurst Resources Limited has announced a substantial increase in its marketable coal reserves, driven by key project developments and positive feasibility studies, while total resources saw a slight decline due to reassessments and mining depletion.

InteliCare successfully completed its largest aged care pilot at mecwacare’s Trescowthick Centre and secured $2 million in funding, while navigating a key leadership transition.

Strategic Elements Ltd has marked a key milestone by successfully fabricating Energy Ink™ prototype cells in a commercial setting, while expanding its artificial intelligence ventures and maintaining a robust financial position.